FDA approves Humira in Orphan eye indication

AbbVie Inc. (NYSE:ABBV) said FDA approved Humira adalimumab to treat

Read the full 104 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE